InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001415889-23-002511 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-14 2023-02-10+ HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 +3,892 6,545 +147% $0
DM 2023-02-14 2023-02-10+ HALO LaBrosse Nicole SVP, CFO F - Tax $48.92 -2,073 5,156 -29% -$101.4K
DM 2023-02-14 2023-02-10+ HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 -3,892 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-10 M A 2,503 $0.00 6,548 D — —
2 Common Common Stock 2023-02-12 F D 681 $48.92 5,864 D — — (F2) The reported disposition of 681 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
3 Common Common Stock 2023-02-12 M A 1,389 $0.00 6,545 D — —
4 Common Common Stock 2023-02-10 F D 1,392 $48.92 5,156 D — — (F1) The reported disposition of 1,392 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
5 Derivative Restricted Stock Units 2023-02-10 M D 2,503 $0.00 2,502 D $0.00 · — to — 2,503 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2023-02-12 M D 1,389 $0.00 0 D $0.00 · — to — 1,389 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.